Insphero is a pioneering biotechnology company specializing in 3D cell culture technology. They develop and commercialize advanced 3D microtissues and assay solutions for drug discovery, efficacy and safety testing, and biomedical research. Insphero's platforms, including their Akura™ technology, enable more physiologically relevant and predictive in vitro testing, aiming to improve the efficiency of drug development and reduce reliance on animal models. They serve pharmaceutical, biotechnology, cosmetic, and chemical industries, as well as academic research institutions worldwide.
Global headquarters, primary research and development (R&D) center, manufacturing hub for 3D microtissues, and corporate administration.
State-of-the-art laboratories equipped for advanced 3D cell culture, high-content imaging, bio-analytics, and automated production. Location within the Bio-Technopark provides access to a rich ecosystem of biotech companies and research institutions.
A highly innovative and collaborative environment, driven by scientific excellence and precision. The culture fosters interdisciplinary teamwork, continuous learning, and a commitment to advancing in vitro technologies.
The headquarters is the nerve center for Insphero's innovation, product development, and global operations. Its strategic location in a leading European biotech cluster facilitates collaborations and access to talent.
Insphero supports its global clientele, which includes leading pharmaceutical, biotech, cosmetic, and chemical companies, as well as academic institutions, through its headquarters in Switzerland, a subsidiary in the USA (Brunswick, ME), and an office in Germany. They also leverage a network of distribution partners in key Asian markets and other regions to ensure worldwide access to their 3D in vitro models and services. Their global functions include direct sales, technical support, collaborative research projects, and assay services.
Wagistrasse 27a
Schlieren
Zurich
Switzerland
Address: Brunswick Landing, 15 Terminal Road, Suite 230, Brunswick, ME 04011, USA
To directly serve and expand Insphero's presence in the significant North American pharmaceutical, biotech, and research sectors, offering localized expertise, faster support, and tailored solutions.
Address: Bismarckstrasse 6, 79761 Waldshut-Tiengen, Germany
To strengthen Insphero's operational footprint and customer engagement within Germany, a key European market for life sciences and pharmaceutical research.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, InSphero ' leadership includes:
InSphero has been backed by several prominent investors over the years, including:
Based on publicly available information, Insphero has not announced major executive hires or departures in the last 12 months. The current leadership team appears stable, continuing to guide the company's growth and innovation.
Discover the tools InSphero uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Insphero AG commonly utilizes email formats based on employee names. The most prevalent structure appears to be [first].[last]@insphero.com. While other formats might exist within the organization, this pattern is a strong starting point for professional communication.
[first].[last]@insphero.com
Format
jane.doe@insphero.com
Example
80%
Success rate
Insphero Website • May 14, 2024
Insphero AG announced a strategic collaboration with BIOIVT to enhance drug discovery and development by combining Insphero’s 3D Human Liver Microtissues with BIOIVT’s extensive portfolio of hepatocytes and liver-derived products....more
Insphero Website • February 20, 2024
Insphero launched its Akura™ Perfused Multi-Organ-System, a scalable, plate-based solution designed to interconnect different 3D microtissue models for advanced in vitro ADME-Tox studies, mimicking complex organ interactions....more
Insphero Website • November 7, 2023
Insphero announced the renewal of its long-standing collaboration with Roche to further develop and apply 3D microtissue-based assays for more predictive assessment of drug safety profiles in preclinical development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including InSphero , are just a search away.